Back

Real-world efficacy and safety of the subcutaneous implantable cardioverter defibrillator

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Implantable cardioverter-defibrillator therapy Device Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Nikias Milaras

Ippokrateio General Hospital of Athens, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Predicting ICD therapy events through machine learning: bridging clinical predictors and device data
Doctor T. Chiba (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Complete system explantation versus conservative treatment in patients with infections of Implantable Cardioverter Defibrillators.
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract Slides Video
Presentation thumbnail
Subcutaneous ICD therapy in patients with monomorphic ventricular tachycardia: arrhythmia recurrence, shock burden, and management strategies
Doctor G. Botto (Garbagnate Milanese, IT)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes after subcutaneous implantable cardioverter-defibrillator implantation in patients with genetic cardiac arrhythmias
Doctor Y. Matsuda (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Concordance of calculated arrhythmic risk and guideline-directed ICD indication in PKP2-related ARVC
Ms L. Rekker (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Implantable cardioverter-defibrillator therapy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Subcutaneous ICD therapy after sternotomy: feasibility and long-term outcomes in a propensity-matched analysis from a national registry
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy
thumbnail
Congress Presentation
Two-versus three-incision techniques for subcutaneous implantable cardioverter-defibrillator implantation: insights from the HONEST registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources